People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

in its US$25 million at-the-market equity offering of voting shares


in Ontario Securities Commission enforcement proceedings against Cormark Securities

in its C$4-million private placement of units, comprised of a common share and a warrant

in a stalking horse purchase agreement for the business and assets by SNDL

in its US$5-million offering of debentures, the first such offering by a publicly-traded cannabis company to be backed by Bitcoin


in the sale of a portfolio of  Canadian health care clinics

in its acquisition of Siam Ventures, and in its concurrent C$2-million private share placement


in its preliminary shelf prospectus filing

in filing its C$35-million short-form base shelf prospectus and C$20-million at-the-market offering

in its strategic partnership with SNDL, which includes the provision of certain licenses to operate and IP rights to SNDL

in connection with a statutory plan of arrangement whereby SNDL acquired all of the issued and outstanding shares


in the establishment of an on-reserve cannabis production and retail operations in British Columbia, Saskatchewan and Ontario

in its US$400-million term loan facility and  US$25-million construction mortgage financing

in its US$2-billion acquisition of Columbia Care

in its US$125-million offering of subordinate voting shares

in a public offering of 7,350,000 units at a price per unit of $10.00 for gross proceeds of $73,500,000

in its US$207-million acquisition of Bluma Wellness

in its $2.2-billion reverse takeover transaction and public listing on the Canadian Securities Exchange

in its $1.1-billion acquisition of Origin House

in the successful campaign to refresh the board of directors of HEXO, reducing the board to seven members, with KAOS retaining right to nominate an eighth member

in its $133 million acquisition of Canna Farms

in its arrangement with Canopy USA, LLC to convert $125.5M in debt to securities

in the $7.14-million private placement offering of The Flowr Corporation

in an up to $30-million at-the-market equity program for the sale of common shares pursuant to an equity distribution agreement with Aleafia Health

in the $22.7-million bought deal offering of units of Aleafia Health&nbsp;

in the $33.4-million bought deal equity financing of units of MediPharm Labs&nbsp;

in the $15.9-million bought deal short form prospectus offering of The Flowr Corporation

in an at-the-market equity offering for the sale of up to $39 million of common shares pursuant to an equity distribution agreement with GMP Securities

in its prospectus offering of common shares to a single institutional investor for gross proceeds of $10.8 million

in its acquisition of Québec-based licensed producer Agro-Biotech

in its strategic alliance agreement with Honest

in the acquisition of Robinson's Cannabis Incorporated valued at $14,000,000

in the brokered private placement of convertible debentures of Central Coast Agriculture for aggregate gross proceeds of up to US$25 million

in the brokered private placement of special warrants of CLS Holdings USA for aggregate gross proceeds of $13 million

in the brokered private placement of convertible debentures of CLS Holdings USA for aggregate gross proceeds of up to US$20 million

in the brokered private placement of units of LiveWell Foods Canada for aggregate gross proceeds of $10 million

in its acquisition of Canada’s Island Garden

in its business combination with Sante Veritas Holdings and others

in its non-brokered private placement of $2,131,690.00 of units

in corporate, regulatory and IP matter related to Hebrew University, Agricultural Research Organization and ongoing corporate and financing needs

in its bought-deal short-form prospectus offering of units for gross proceeds of $28.75 million

in its supply agreement with, and ultimate acquisition of, Good & Green

go-public transaction with Kramer Capital

in its acquisition of Israel clinical pharma Therapix Bioscience

amalgamation with Century Financial Capital Group

Cannabis Law

Overview

Key Contacts


Bennett Jones Cannabis Law We advise cannabis businesses across Canada on regulation, financing and transactions, offering legal and business insight that drives long-term success. Key Contacts Angela BlakePartner Dominique T. HusseyChief Executive Officer Aaron E. SonshinePartner Jean TessierPartner Jon C. TruswellPartner Julia Qian WangPartner Overview Bennett Jones' cannabis group consists of a team of dedicated legal professionals based mainly in Toronto with expertise spread throughout our additional offices in Canada. We are focused on providing services and expertise designed to enhance the prospects of our cannabis clients. We deliver high-quality legal services with an entrepreneurial approach. Key Contacts Angela Blake, Partner Toronto, Vancouver • 416.777.4889 • blakea@bennettjones.com Dominique T. Hussey, Chief Executive Officer • Co-Head of Innovation, Technology & Branding Practice Toronto • 416.777.6230 • husseyd@bennettjones.com Aaron E. Sonshine, Partner Toronto • 416.777.6448 • sonshinea@bennettjones.com Jean Tessier, Partner Montréal • 514.985.4527 • tessierj@bennettjones.com Jon C. Truswell, Partner Calgary • 403.298.3097 • truswellj@bennettjones.com Julia Qian Wang, Partner Montréal • 514.985.4540 • wangju@bennettjones.com